Market Announcement 29 October 2026 Noxopharm Limited (ASX: NOX) – Suspension from Quotation The securities of Noxopharm Limited (‘NOX’) will be suspended from quotation immediately under Listing Rule 17.2 at the request of NOX, pending the release of an announcement by NOX. Unless ASX...
Voluntary Suspension
Filed with ASX ·
6ix is reading this filing.
Earlier from Noxopharm
- Trading Halt
- Novel oligonucleotides data presented at Options Conference
- Appendix 4E - Preliminary Financial Report
- New preclinical data supports immuno-oncology approach
- Quarterly Activities/Appendix 4C Cash Flow Report
Later from Noxopharm
All Noxopharm news releasesFollow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm